Literature DB >> 3010806

Cellular mechanisms of cholestasis.

D G Oelberg, R Lester.   

Abstract

Concepts regarding the pathogenesis of cholestasis continue to evolve as investigational techniques improve and molecular mechanisms of bile formation are clarified. With the accumulation of information it is becoming increasingly evident that cholestasis results from not one but multiple disturbances in the sequence of events responsible for bile production. In addition to the inhibition of bile flow attributable to initiating events, cholestasis itself may inhibit bile flow by altering the intra- and extracellular environments of liver cells. Many questions about cholestasis remain unanswered, but future directions for research are suggested by the information currently available.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010806     DOI: 10.1146/annurev.me.37.020186.001501

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  10 in total

1.  S-adenosyl-L-methionine reverses the cholestatic effect of ethinylestradiol in rat hepatocytes by increasing its catabolism.

Authors:  A Larrauri; J V Castell; G Garrido; J Berenguer; M J Gómez-Lechón
Journal:  Cell Biol Toxicol       Date:  1992 Jan-Mar       Impact factor: 6.691

2.  Therapeutic effect of secretin in patients with jaundice; double-blind placebo-controlled multicentric trial.

Authors:  Y Fukumoto; K Okita; T Kodama; S Matsuda; S Kawamura; K Harima; Y Harada; K Kawaguchi; Y Iida; T Konishi; K Andoh; H Tanaka; T Hanta; T Sekitani; T Takenami; T Yamasaki; S Yamashita; H Fujimura; M Shimada; M Kohzu; K Shigeta; H Shirasawa
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Release of Ca2+ from the endoplasmic reticulum is not the mechanism for bile acid-induced cholestasis and hepatotoxicity in the intact rat liver.

Authors:  G C Farrell; S K Duddy; G E Kass; J Llopis; A Gahm; S Orrenius
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

4.  Hepatic immunohistochemical localization of the tight junction protein ZO-1 in rat models of cholestasis.

Authors:  J M Anderson; J L Glade; B R Stevenson; J L Boyer; M S Mooseker
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

5.  Alpha-fetoprotein, tissue polypeptide antigen and ferritin in diagnosing primary hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  G Leandro; D Basso; C Fabris; S Zizzari; S Elba; G Del Favero; F Di Mario; T Meggiato; C Angonese; R Naccarato
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 6.  Cellular mechanisms of intrahepatic cholestasis.

Authors:  P J Meier-Abt
Journal:  Drugs       Date:  1990       Impact factor: 9.546

7.  Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis.

Authors:  D Basso; C Fabris; M Plebani; G Del Favero; M Muraca; M T Vilei; M P Panozzo; T Meggiato; P Fogar; A Burlina
Journal:  Clin Investig       Date:  1992-01

Review 8.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

9.  Bile acids increase cellular free calcium in cultured kidney cells (LLC-PK).

Authors:  M H Montrose; R Lester; P Zimniak; M S Anwer; H Murer
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

10.  Effects of taurolithocholate, a Ca2(+)-mobilizing agent, on cell Ca2(+) in rat hepatocytes, human platelets and neuroblastoma NG108-15 cell line.

Authors:  J F Coquil; B Berthon; N Chomiki; L Combettes; P Jourdon; C Schteingart; S Erlinger; M Claret
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.